Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India
· Delayed Price · Currency is INR 211.78
-0.48 (-0.23%)
May 20, 2025, 9:30 AM IST
Jagsonpal Pharmaceuticals Market Cap
Jagsonpal Pharmaceuticals has a market cap or net worth of 14.10 billion as of May 19, 2025. Its market cap has increased by 55.26% in one year.
Market Cap
14.10B
Enterprise Value
12.91B
Revenue
2.69B
Ranking
n/a
PE Ratio
25.82
Stock Price
211.78
Market Cap Chart
Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 14.10B, a decrease of -20.02%. That is a compound annual growth rate of -0.88%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,162.61B |
| Divi's Laboratories | 1,667.01B |
| Cipla | 1,211.38B |
| Mankind Pharma | 1,061.44B |
| Apollo Hospitals Enterprise | 1,008.65B |
| Zydus Lifesciences | 908.33B |
| Aurobindo Pharma | 697.66B |
| Alkem Laboratories | 624.25B |